Santori & Peters Inc’s DexCom DXCM Stock Holding History

Santori & Peters Inc’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,148	Closed	-$15K	–	190
2017 Q4	$15K	Buy	+1,148	New	+$14.9K	0.01%	237

Other funds holding DXCM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Santori & Peters Inc's DXCM Position: Q1 2018 in Review

Santori & Peters Inc sold out of DexCom (DXCM) in Q1 2018, closing a stake of 1,148 shares — an estimated $15K sold.

Santori & Peters Inc first reported a position in DXCM in Q4 2017 and held it in 1 quarter. The position peaked at $15K in Q4 2017. 276 funds tracked by Wall St. Rank hold DXCM as of Q1 2018.

Santori & Peters Inc reported no remaining DexCom position as of Q1 2018 after selling out during the quarter.
Santori & Peters Inc sold 1,148 DexCom shares in Q1 2018, an estimated $15K.
Santori & Peters Inc first reported a position in DexCom in Q4 2017 and held it in 1 quarter.
Santori & Peters Inc's DexCom position peaked at $15K in Q4 2017.
276 funds tracked by Wall St. Rank held DexCom as of Q1 2018.

Based on Santori & Peters Inc's 13F filing for Q1 2018, filed 16 Apr 2018.